Disease: nosocomial infections

Functional Amyloids in Adhesion of Non-albicans Candida Species

Candida fungi cause common infections and form tough biofilms that resist treatment. These fungi stick to body surfaces using proteins called adhesins that form amyloid-like structures. Researchers found that special peptides can block these amyloid structures in several Candida species, preventing them from sticking to cells and potentially offering a new way to fight these infections.

Read More »

Detection of Multiple Nosocomial Trichosporon asahii Transmission Events via Microsatellite Typing Assay, South America

Researchers developed a new genetic fingerprinting test to track and identify outbreaks of a dangerous fungal infection called Trichosporon asahii in hospitals across South America. The test uses microsatellite markers to create a detailed genetic profile of different fungal isolates, making it much better at detecting when infections spread from patient to patient compared to older methods. This discovery revealed multiple hidden disease clusters in hospitals, including one that occurred over 13 years, highlighting the importance of this new surveillance tool for hospital infection control.

Read More »

Breaking down biofilms across critical priority fungal pathogens: proteomics and computational innovation for mechanistic insights and new target discovery

This comprehensive review examines how scientists are fighting dangerous fungal infections that form protective biofilms resistant to current antifungal drugs. Researchers are using advanced protein analysis techniques (proteomics) and artificial intelligence-based computational tools to identify new targets for drug development against four critical fungal pathogens that cause life-threatening infections like meningitis and lung infections. By combining these technologies, scientists can better understand how these fungal biofilms form and develop more effective treatments.

Read More »

Brown locusts, Locustana pardalina, host fluconazole-resistant Candidozyma (Candida) auris, closely related to Clade III clinical strains

Scientists found that brown locusts in South Africa carry a dangerous yeast called Candida auris that is resistant to the antifungal drug fluconazole. This yeast is similar to strains that infect hospital patients and is highly adaptable, surviving extreme temperatures and salt levels found in locust guts. This discovery suggests that insects like locusts could play a role in spreading this emerging fungal pathogen in nature, which has important implications for understanding how dangerous microbes spread between animals and humans.

Read More »

Detection of Multiple Nosocomial Trichosporon asahii Transmission Events via Microsatellite Typing Assay, South America

Researchers developed a genetic fingerprinting tool called microsatellite typing to track and identify outbreaks of a dangerous fungus called Trichosporon asahii in hospitals. This fungus causes life-threatening infections, especially in sick patients with weakened immune systems, and is resistant to many antifungal medications. By analyzing samples from hospitals across South America, scientists discovered multiple instances where the same strain of this fungus infected patients in different hospitals over many years. This new testing method is much cheaper and faster than other genetic tests, making it practical for hospitals worldwide to monitor and control infections caused by this emerging pathogen.

Read More »

Characterization of ORF19.7608 (PPP1), a biofilm-induced gene of Candida albicans

Researchers studied a gene called PPP1 in Candida albicans, a common fungal infection in hospitals. They found that this gene is highly active when the fungus forms protective biofilms on medical devices like catheters. Although the protein appears in a distinctive spotted pattern only during biofilm formation, removing this gene did not prevent biofilm formation or affect how the fungus responds to stress or antifungal drugs.

Read More »

Breaking down biofilms across critical priority fungal pathogens: proteomics and computational innovation for mechanistic insights and new target discovery

Fungal infections like cryptococcal meningitis and invasive aspergillosis are becoming increasingly difficult to treat because fungi form protective structures called biofilms that resist our current medications. Researchers are using advanced techniques like mass spectrometry to identify the proteins that help fungi build these biofilms, combined with artificial intelligence tools to design new drugs that could break down these protective shields. This combined approach offers hope for developing better antifungal treatments that could save millions of lives.

Read More »

Brown locusts, Locustana pardalina, host fluconazole-resistant Candidozyma (Candida) auris, closely related to Clade III clinical strains

Researchers discovered that brown locusts in South Africa can carry a dangerous drug-resistant fungus called Candida auris in their digestive systems. This fungus, which causes serious infections in hospitals and is resistant to the antifungal drug fluconazole, may use locusts as a way to spread to humans or other environments. The study suggests that insects could play an important role in how dangerous fungi emerge and spread globally, particularly in warm climates where locusts thrive.

Read More »
Scroll to Top